Jeffrey Garro
Stock Analyst at Stephens
(0.10)
# 4,807
Out of 5,118 analysts
65
Total ratings
32.8%
Success rate
-20.8%
Average return
Main Sectors:
Stocks Rated by Jeffrey Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx | Rated: Hold | $10 → $7 | $8.76 | -20.09% | 6 | May 13, 2026 | |
| CERT Certara | Reiterated: Buy | $12 → $9 | $12.05 | -25.31% | 6 | May 12, 2026 | |
| HCAT Health Catalyst | Reiterated: Hold | $2 → $1.75 | $1.46 | +19.86% | 5 | May 12, 2026 | |
| PHR Phreesia | Reiterated: Buy | $37 → $20 | $12.62 | +58.48% | 3 | Mar 31, 2026 | |
| DH Definitive Healthcare | Reiterated: Hold | $5 → $3 | $1.15 | +160.87% | 2 | Feb 27, 2026 | |
| EVH Evolent Health | Reiterated: Buy | $7 | $4.58 | +52.84% | 4 | Feb 25, 2026 | |
| TDOC Teladoc Health | Reiterated: Hold | $8 | $8.77 | n/a | 1 | Apr 30, 2025 | |
| PRVA Privia Health Group | Reiterated: Buy | $26 → $30 | $24.42 | n/a | 3 | Mar 5, 2025 | |
| MDRX Veradigm Inc. | Reiterated: Hold | $13 → $7 | $4.80 | n/a | 9 | Jan 31, 2025 | |
| DOCS Doximity | Initiated Coverage: Hold | $55 | $32.51 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $255 → $250 | $271.83 | n/a | 3 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $280 | $303.73 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $20 | $7.34 | n/a | 5 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 → $3.9 | $8.97 | n/a | 8 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3 | $0.4801 | n/a | 7 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $116.10 | n/a | 1 | Dec 20, 2021 |
OptimizeRx
May 13, 2026
Rated: Hold
Price Target: $10 → $7
Current: $8.76
Upside: -20.09%
Certara
May 12, 2026
Reiterated: Buy
Price Target: $12 → $9
Current: $12.05
Upside: -25.31%
Health Catalyst
May 12, 2026
Reiterated: Hold
Price Target: $2 → $1.75
Current: $1.46
Upside: +19.86%
Phreesia
Mar 31, 2026
Reiterated: Buy
Price Target: $37 → $20
Current: $12.62
Upside: +58.48%
Definitive Healthcare
Feb 27, 2026
Reiterated: Hold
Price Target: $5 → $3
Current: $1.15
Upside: +160.87%
Evolent Health
Feb 25, 2026
Reiterated: Buy
Price Target: $7
Current: $4.58
Upside: +52.84%
Teladoc Health
Apr 30, 2025
Reiterated: Hold
Price Target: $8
Current: $8.77
Upside: n/a
Privia Health Group
Mar 5, 2025
Reiterated: Buy
Price Target: $26 → $30
Current: $24.42
Upside: n/a
Veradigm Inc.
Jan 31, 2025
Reiterated: Hold
Price Target: $13 → $7
Current: $4.80
Upside: n/a
Doximity
Dec 19, 2024
Initiated Coverage: Hold
Price Target: $55
Current: $32.51
Upside: n/a
Dec 19, 2024
Initiated Coverage: Buy
Price Target: $255 → $250
Current: $271.83
Upside: n/a
Dec 19, 2024
Initiated Coverage: Buy
Price Target: $280
Current: $303.73
Upside: n/a
Aug 5, 2022
Reiterated: Buy
Price Target: $15 → $20
Current: $7.34
Upside: n/a
May 11, 2022
Reiterated: Sell
Price Target: $5 → $3.9
Current: $8.97
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: $4 → $3
Current: $0.4801
Upside: n/a
Dec 20, 2021
Reiterated: Buy
Price Target: n/a
Current: $116.10
Upside: n/a